期刊文献+

定量检测PD-1单克隆抗体ELISA法的建立 被引量:2

Development and application of ELISA method for quantitative detection of PD-1 monoclonal antibody
下载PDF
导出
摘要 目的建立一种高特异、高灵敏、新型的定量检测食蟹猴血清中PD-1单克隆抗体质量浓度的ELISA方法。方法用重组人PD-1作为抗原包被到96孔板上,加入系列浓度标准品(PD-1单克隆抗体)和稀释的食蟹猴血清,再加入稀释的猴血清吸附的羊抗人Ig G-HRP(二抗),二抗与结合到抗原上的PD-1单克隆抗体特异性结合,加入底物显色剂,用硫酸终止,在450 nm下读数。结果在40~0.625 ng/ml范围内,PD-1单克隆抗体质量浓度的对数值与吸光值呈S形曲线,方法灵敏度为0.625 ng/ml,TNF-α、r HSA、PEG-GH和受试品PD-1单克隆抗体均无交叉反应,方法的回收率为94.5%~98.0%,板内精密度波动在-4.1%^-0.1%,板间精密度波动在-5.0%^-1.0%。结论本方法符合新生物制品临床前药代动力学研究指导原则的要求,可用于食蟹猴体内PD-1单克隆抗体的定量检测。 This study was performed to develop a specific and sensitive ELISA method for the quantification of PD-1 monoclonal antibody in eynomolgus monkey serum. Recombinant human PD-1 was coated onto 96-well plates, and then standard preparation of PD-1 monoclonal antibody at different concentrations and diluted cynomolgus serum were added. When PD-1 monoclonal antibody in serum was bound to the recombinant human PD-1 specifically, goat anti-human IgG-HRP (secondary antibody) diluted by monkey serum was added, which then bound to PD-1 monoclonal antibody. Then substrate reagent was added and sulfuric acid was used for quenching, and the optical density at 450 nm was detected. The standard curve of the constructed method was developed with a wide dynamic range of concentrations from 0.625 to 40 ng/ml. The lowest quantification of this assay was 0.625 ng/ml. The specificity assay indicated that PD-1 antibody in samples had no cross-reaction with TNF-α, rHSA, and PEG-GH; the recovery of the method was 94.5%-98.0%, and the precision degree of the intraand inter-assay were varied between -4.1%- -0.1% and -5.0%- -1.0%, respectively. Taken together, this method is consistent with the requirements of the new research guidelines of biological preclinical pharmacokinetics, with highly sensitive, precise, specific, and reproducibility over a wide dynamic range of concentrations, which is proven to be a feasible quantitative method for detection of PD-1 monoclonal antibody in the serum of cynomolgus monkeys.
出处 《免疫学杂志》 CAS CSCD 北大核心 2016年第8期712-715,724,共5页 Immunological Journal
关键词 PD-1单克隆抗体 ELISA 定量检测 药代动力学 PD-1 monoclonal antibody ELISA Quantification Pharmacokinetics
  • 相关文献

参考文献4

二级参考文献68

  • 1Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses[J]. Annu Rev Immunol, 2002, 20: 29-53.
  • 2Ishida Y, Agata Y, Shibahara K, et al. Induced expression of PD-I, a novel member of the immunoglobulin gene superfamily, upon programmed cell death [J]. EMBO J, 1992, 11 (11): 3887-3895.
  • 3Okazaki T, Maeda A, Nishimura H, et al. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine [J]. Proc Natl Acad Sci U S A, 2001, 98 (24): 13866-13871.
  • 4Dong H, Zhu G, Tamada K, et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-lO secretion[J]. Nat Med, 1999, 5 (12): 1365-1369.
  • 5Nishimura H, Nose M, Hiai H, et al. Development of lupus-like autoimmune diseases by disruption of the PD-I gene encoding an ITIM motif-carrying immunoreceptor[J]. Immunity, 1999, 11(2): 141-151.
  • 6Salama AD, Chitnis T, Imitola J, et al. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis [M]. J Exp Med, 2003, 198 (1): 71-78.
  • 7Gao W, Demirci G, Strom TB, et al. Stimulating PD-l-negative signals concurrent with blocking CD 154 co-stimulation induces long-term islet allograft survival[J]. Transplantation, 2003, 76 (6): 994-999.
  • 8Ozkaynak E, Wang L, Goodearl A, et al. Programmed death-1 targeting can promote allograft survival [J]. J Immunol, 2002, 169 (11): 6546-6553.
  • 9Barber DL, Wherry E J, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection [J]. Nature, 2006, 439 (7077): 682-687.
  • 10Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression [J]. Nature, 2006, 443 17109): 350-354.

共引文献32

同被引文献4

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部